IPOPLUS

₹443.2

▲ +4.75 +1.08%

18 Jun 2026

NSE Listed · Healthcare

Dr. Agarwal's Health Care Limited (AGARWALEYE)

Volume: 2,046Avg Vol 1W: 13,683Avg Vol 1M: 31,91352W Range:₹360.6₹568
NSE BSE
₹443.2▲ 1.08%
Key Ratios
Updated just now
Market Cap₹13,950 Cr
Current Price₹443.2
Previous Close₹438.45
High / Low (52w)₹568 / ₹360.6
Volume2,046
Avg Vol (1W)13,683
Avg Vol (1M)31,913
Stock P/E169.28
Book Value₹63.93
Dividend Yield0%
ROE6.58%
ROA4.27%
Revenue (TTM)—
Revenue Growth28.44%
Profit Margin6.4%
Total Debt₹157 Cr
Shares Outstanding32 Cr
Face Value₹1
EPS (TTM)₹1.25
P/B7.25
Debt / Equity0.53
50 DMA₹461.08
200 DMA₹448.13
Day change+1.08%
Price Chart
₹443.2▼ 18.01% · 1Y
₹544₹40533.7L
2025-10-20
2026-06-16

20-day avg volume: 32K shares

Pros
  • Company is almost debt-free.
  • Revenue grew 28% YoY.
Cons
  • Stock trades at a high P/E of 169.
Quarterly Results
MetricMar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023
Revenue₹564 Cr₹530 Cr₹499 Cr₹487 Cr₹460 Cr₹431 Cr₹417 Cr₹403 Cr₹349 Cr₹333 Cr
EBITDA₹97 Cr₹86 Cr₹76 Cr₹78 Cr₹86 Cr₹69 Cr₹62 Cr₹54 Cr₹82 Cr₹58 Cr
Net Profit₹40 Cr₹34 Cr₹30 Cr₹30 Cr₹33 Cr₹22 Cr₹17 Cr₹12 Cr₹39 Cr₹20 Cr
EPS1.241.060.930.951.030.720.450.431.381.94
Profit & Loss (Annual)
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue₹1,757 Cr₹1,376 Cr₹1,031 Cr₹714 Cr₹477 Cr₹544 Cr
EBITDA₹272 Cr₹236 Cr₹156 Cr₹102 Cr₹-7 Cr₹40 Cr
Net Profit₹83 Cr₹83 Cr₹94 Cr₹38 Cr₹-55 Cr₹-21 Cr
EPS2.783.1341.83-80.87-29.93
Balance Sheet
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Total Assets₹3,672 Cr₹2,753 Cr₹1,825 Cr₹1,026 Cr₹787 Cr₹752 Cr
Total Liabilities₹1,745 Cr₹1,373 Cr₹1,166 Cr₹792 Cr₹588 Cr₹485 Cr
Equity₹1,927 Cr₹1,380 Cr₹659 Cr₹234 Cr₹199 Cr₹267 Cr
Total Debt₹157 Cr₹310 Cr₹306 Cr₹254 Cr₹168 Cr₹145 Cr
Cash Flow
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operating₹397 Cr₹378 Cr₹268 Cr₹180 Cr₹107 Cr₹120 Cr
Investing₹-750 Cr₹-914 Cr₹-509 Cr₹-155 Cr₹-37 Cr₹-80 Cr
Financing₹382 Cr₹553 Cr₹303 Cr₹35 Cr₹-37 Cr₹-73 Cr
Free Cash Flow₹385 Cr₹377 Cr₹267 Cr₹180 Cr₹107 Cr₹120 Cr
Shareholding
Promoter 32.36% Institutions 22.6% Public 45.04%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search